| Anti-HT Indications |
FDA Indications of Week 1 & 2 (Anti-HT) |
Science |
2024-10-05 |
Oosagie77 |
25 |
0 |
edit |
|
| Anti-HT CI |
Contraindication of Antihypertensives drugs (weeks 1-2) |
Science |
2024-10-05 |
Oosagie77 |
25 |
0 |
edit |
|
| Anti-HT S/E |
Antihypertension adverse effects (weeks 1-2) |
Science |
2024-10-05 |
Oosagie77 |
25 |
0 |
edit |
|
| Anti-HT monitor |
Antihypertensives Monitoring (Weeks 1-2) |
Unfinished |
2024-10-05 |
Oosagie77 |
29 |
0 |
edit |
|
| BBW Exam 1 |
Black Box Warnings For Exam 1 |
Unfinished |
2024-10-05 |
Oosagie77 |
9 |
0 |
edit |
|
| AntiBio Indications |
Antibiotics FDA Indication Weeks 5-6 |
Unfinished |
2024-10-05 |
Oosagie77 |
20 |
0 |
edit |
|
| AntiBio - CI |
Antibiotics Contraindications |
Unfinished |
2024-10-05 |
Oosagie77 |
15 |
0 |
edit |
|
| AntiMicro - S/E |
Antimicrobial Adverse Effects |
Unfinished |
2024-10-05 |
Oosagie77 |
20 |
0 |
edit |
|
| 509 Group 7 (1/3) |
Medical terms related to blood |
Unfinished |
2024-10-05 |
Oosagie77 |
12 |
0 |
edit |
|
| 509 Group 7 (2/3) |
Medical terms of the respiratory system |
Medical |
2024-10-05 |
Oosagie77 |
11 |
0 |
edit |
|
| 509 Group 7 (3/3) |
Medical Terms of the Urinary System |
Unfinished |
2024-10-05 |
Oosagie77 |
7 |
0 |
edit |
|
| 509 Group 8 (1/2) |
Medical Terms of the reproductive system |
Unfinished |
2024-10-05 |
Oosagie77 |
12 |
0 |
edit |
|
| 509 Group 8 (2/2) |
Medical Terms of the Digestive system |
Unfinished |
2024-10-05 |
Oosagie77 |
13 |
0 |
edit |
|
| Stack #4279269 |
Drug List Exam 2 |
Unfinished |
2024-10-11 |
Oosagie77 |
14 |
0 |
edit |
|
| 509 Group 9 |
Integumentary (skin) + Skeletal system |
Anatomy |
2024-10-13 |
Oosagie77 |
21 |
0 |
edit |
|
| 509 Group 10 |
Muscular, Ophthalmic and Auditory system |
Anatomy |
2024-10-13 |
Oosagie77 |
24 |
0 |
edit |
|
| 507 Pain FDA Ind. |
FDA indications of Pain medication |
Unfinished |
2024-10-13 |
Oosagie77 |
11 |
0 |
edit |
|
| 507 Pain CI |
Pain Meds Contraindications |
Unfinished |
2024-10-13 |
Oosagie77 |
11 |
0 |
edit |
|
| 507 Pain S/E |
Pain medications s/e, |
Unfinished |
2024-10-13 |
Oosagie77 |
11 |
0 |
edit |
|
| 509 Pain monitoring |
Pain medications monitoring |
Unfinished |
2024-10-13 |
Oosagie77 |
11 |
0 |
edit |
|
| Mixed b-antagonists |
502 Exam 2 third generation beta antagonists |
Unfinished |
2024-10-15 |
Oosagie77 |
6 |
0 |
edit |
|
| Beta 1 antagonists |
502 Exam 2 (1st and 2nd gen beta-antagonists) |
Unfinished |
2024-10-15 |
Oosagie77 |
6 |
0 |
edit |
|
| alpha antagonists |
502 exam 2 alpha antagonists |
Unfinished |
2024-10-15 |
Oosagie77 |
6 |
0 |
edit |
|
| 509 Finals |
509 Group 2 |
Medical |
2024-11-16 |
Oosagie77 |
100 |
0 |
edit |
|
| 509 Group 3 |
509 Group 3 |
Unfinished |
2024-11-17 |
Oosagie77 |
24 |
0 |
edit |
|
| 509 ALL MED TERMS |
509 ALL MED TERMS |
Medical |
2024-11-17 |
Oosagie77 |
217 |
0 |
edit |
|
| TOP 200 Final |
Everything |
Unfinished |
2024-12-07 |
Oosagie77 |
38 |
0 |
edit |
|
| Top200 Endocrine pt2 |
Top200 Endocrine pt2 |
Unfinished |
2025-02-07 |
Oosagie77 |
58 |
0 |
edit |
|
| 514 Comp Exam 2 |
Everything in Red |
Science |
2025-02-06 |
Oosagie77 |
23 |
0 |
edit |
|
| 512 Exam 1 |
512 Exam 1 |
Unfinished |
2025-02-16 |
Oosagie77 |
20 |
0 |
edit |
|
| 512 Exam 1 - pt.4 |
Hepatobilliary Pathophys |
Unfinished |
2025-02-17 |
Oosagie77 |
28 |
0 |
edit |
|